의료 AI 시장 규모, 점유율 및 동향 분석 보고서 : 용도별, 최종 용도별, 환자 여정별, 지역별 및 부문별 예측(2026-2036년)

Medical AI Market Summary

The global medical AI market size was estimated at USD 42.62 billion in 2025 and is projected to grow from USD 56.20 billion in 2026 to USD 1,050.63 billion by 2036, at a CAGR of 34.0% from 2026 to 2036. The North America Medical AI market held the largest share of 44.01% of the global market in 2025.

Increasing demand for minimally invasive surgery and clinical precision, growing adoption of real-time health tracking and personalized wellness solutions, increasing demand for minimally invasive surgery and clinical precision, and rising demand for cost-effective drug development are significant factors contributing to market growth.

Global Medical AI Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2036. For this study, Grand View Research has segmented the medical AI market report based on, end use, application, patient journey, and region:

• Application Outlook (Revenue, USD Million, 2021 - 2036)
• Medical Imaging Diagnostics AI
• Digital Pathology AI
• Genomic Diagnostics AI
• Bio-signal Diagnostics/Physiologic Signal AI
• Multimodal Diagnostics AI
• Clinical & Treatment Support
• Robot-Assisted Surgery
• Virtual Assistants
• Administrative Workflow Assistants
• Clinical Trials
• Fraud Detection
• Cybersecurity
• Dosage Error Reduction
• Precision medicine
• Drug discovery & development
• Lifestyle management & remote patient monitoring
• Wearables
• Patient engagement
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2036)
• Healthcare Providers
  • Hospitals
  • Physician groups/clinics
  • Ambulatory / specialty care centers
  • Others (Dialysis centers, Cardiac diagnostic centers, etc.)
• Life Sciences
  • Pharmaceutical companies
  • Biotechnology companies
  • CROs / clinical research organizations
• Patient
• Payer
• Others (Academic medical centers, Research institutes, etc.)
• Patient Journey Outlook (Revenue, USD Million, 2021 - 2036)
• Prevention/Wellness
• Diagnostics
• Treatment / Intervention
• Post-care / Management
• Regional Outlook (Revenue, USD Million, 2021 - 2036)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation And Scope
  • 1.1.1. Segment Definition
    • 1.1.1.1. Application Segment
    • 1.1.1.2. End Use Segment
• 1.2. Regional Scope
  • 1.2.1. Estimates And Forecast Timeline
• 1.3. Objectives
  • 1.3.1. Objective - 1
  • 1.3.2. Objective - 2
  • 1.3.3. Objective - 3
• 1.4. Research Methodology
• 1.5. Information Procurement
• 1.6. Market-specific Research Models
  • 1.6.1. Consensus-based Estimates & Forecasting
  • 1.6.2. Model 1: Commodity Flow Analysis
  • 1.6.3. Model 2: Parent Market Analysis
  • 1.6.4. Model 3: Country-level Multivariate Analysis Assumptions
  • 1.6.5. Model 4: Segment-level Multivariate Analysis Assumptions
    • 1.6.5.1. Medical AI Market CAGR Calculation
    • 1.6.5.2. Variables Used For Market Analysis
    • 1.6.5.3. Regional Analysis Matrix
• 1.7 List Of Secondary Sources
• 1.8 List Of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Application Segment Outlook - Part 1
• 2.3. Application Segment Outlook - Part 2
• 2.4. End Use And Patient Journey Segment Outlook
• 2.5. Competitive Landscape

Chapter 3. Market Variables, Trends & Scope

• 3.1. Market Dynamics
  • 3.1.1. Market Driver Analysis
    • 3.1.1.1. Growing Adoption Of Real-time Health Tracking And Personalized Wellness Solutions
    • 3.1.1.2. Rising Prevalence Of Cancer And Increasing Demand For Early Detection And Classification Of Cancer
      • 3.1.1.2.1. Case Study 1
    • 3.1.1.3. Increasing Demand For Minimally Invasive Surgery And Clinical Precision
    • 3.1.1.4. Rising Demand For Cost-effective Drug Development
    • 3.1.1.5. Growing Focus On Precision Medicine And Targeted Drug Development
      • 3.1.1.5.1. Case Study 2
      • 3.1.1.5.2. Case Study 3
      • 3.1.1.5.3. Targeted Drug Development
    • 3.1.1.6. Increasing Clinical Trials In Drug Repurposing
    • 3.1.1.7. Growing Focus On Remote Patient Monitoring
  • 3.1.2. Market Restraint Analysis
    • 3.1.2.1. Cybersecurity And Privacy Concerns
    • 3.1.2.2. Highly Regulated Industry
    • 3.1.2.3. Limited Measurement Accuracy And Insufficient Clinical Validation
  • 3.1.3. Market Opportunity Analysis
    • 3.1.3.1. Opportunities In Digital Pathology AI Market
      • 3.1.3.1.1. Emergence Of Quantitative Continuous Scoring (QCS) In Digital Pathology
    • 3.1.3.2. Opportunities In AI In Drug Discovery Market
      • 3.1.3.2.1. Quantum Simulation As An Emerging Technology in AI-Enabled Drug Discovery
        • 3.1.3.2.1.1. Use Case Analysis: Kvantify Transforms Quantum Simulations For Drug Discovery With Gefion Supercomputer
      • 3.1.3.2.2. New AI-based Repurposing Approaches
      • 3.1.3.2.3. Disease- And Population-level Opportunities
    • 3.1.3.3. Opportunities In Wearable AI Market
      • 3.1.3.3.1. Gesture Recognition And Contactless Interaction
  • 3.1.4. Market Challenges Analysis
    • 3.1.4.1. Interoperability And Ecosystem Integration
    • 3.1.4.2. High Implementation And Procurement Costs
• 3.2. Recent Developments In The AI In Drug Discovery Market
• 3.3. Recent Developments In The AI In Medical Imaging Market
• 3.4. Technological Overview
  • 3.4.1. Technological Trends In AI In Drug Discovery
    • 3.4.1.1. Advanced Algorithm Integration, Machine Learning, And Data Analytics In Drug Discovery
  • 3.4.2. Technological Trends In Digital Pathology/Computational Pathology AI
• 3.5. Case Study Insights: AI In Drug Discovery
  • 3.5.1. Case Study 1: AI-driven Molecular Intelligence For Accelerated Drug Discovery
  • 3.5.2. Case Study 2: Syneos Health Accelerates Clinical Trials With Azure OpenAI Service
  • 3.5.3. Case Study 3: Novo Nordisk Transforms Clinical Study Reports With Generative AI
  • 3.5.4. Case Study 4: Accelerating Drug Ranking With Wipro Limited's AI System
  • 3.5.5. Case Study 5: Deepdrug Framework For Alzheimer's Disease
• 3.6. Case Study Insights: Computational Pathology
  • 3.6.1. Case Study 1: AI-enhanced Detection Of High-risk Prostate Cancer Features With Aiforia Prostate Cancer Suite
  • 3.6.2. Case Study 2: Building Tools For Machine Learning And Artificial Intelligence In Computational Pathology
• 3.7. Case Study Insights: AI In Medical Imaging
  • 3.7.1. Case Study 1: Enhancing Echocardiography Workflow And Ergonomics With GE Healthcare's Vivid AI Ultrasound System
  • 3.7.2. Case Study 2: Accelerating ECG Diagnosis And Patient Care At Cardioparc With Cardiomatics AI-powered Analysis
• 3.8. Case Study Insights: AI In Administrative Workflow
  • 3.8.1. Case Study 1: Transforming Front Desk Efficiency With Conversational AI In A Small Outpatient Clinic
• 3.9. Business Environment Analysis Tools
  • 3.9.1. Porter's Five Forces Analysis
  • 3.9.2. Pestel Analysis

Chapter 4. Medical AI Market: Application Estimates & Trend Analysis

• 4.1. Medical AI Market: Application Segment Dashboard
• 4.2. Medical AI Market: Application Segment Dashboard
• 4.3. Medical AI Market: Application Analysis, 2025 & 2036
• 4.4. Medical AI Market: Application Analysis, 2025 & 2036
• 4.5. Medical AI Market, By Application, 2021 - 2036 (USD Billion)
• 4.6. Medical Imaging Diagnostics AI
  • 4.6.1. Medical Imaging Diagnostics AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.7. Digital Pathology AI
  • 4.7.1. Digital Pathology AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.8. Genomic Diagnostics AI
  • 4.8.1. Genomic Diagnostics AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.9. Bio-signal Diagnostics/Physiologic Signal AI
  • 4.9.1. Bio-signal Diagnostics/Physiologic Signal AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.10. Multimodal Diagnostics AI
  • 4.10.1. Multimodal Diagnostics AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.11. Clinical & Treatment Support
  • 4.11.1. Clinical & Treatment Support Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.12. Robot-assisted Surgery
  • 4.12.1. Robot-assisted Surgery Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.13. Virtual Assistants
  • 4.13.1. Virtual Assistants Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.14. Administrative Workflow Assistants
  • 4.14.1. Administrative Workflow Assistants Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.15. Clinical Trials
  • 4.15.1. Clinical Trials Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.16. Fraud Detection
  • 4.16.1. Fraud Detection Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.17. Cybersecurity
  • 4.17.1. Cybersecurity Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.18. Dosage Error Reduction
  • 4.18.1. Dosage Error Reduction Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.19. Precision Medicine
  • 4.19.1. Precision Medicine Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.20. Drug Discovery & Development
  • 4.20.1. Drug Discovery & Development Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.21. Lifestyle Management & Remote Patient Monitoring
  • 4.21.1. Lifestyle Management & Remote Patient Monitoring Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.22. Wearable AI
  • 4.22.1. Wearable AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.23. Patient
  • 4.23.1. Patient Engagement Market Estimates And Forecasts, 2021 - 2036 (USD Million)
• 4.24. Others
  • 4.24.1. Others Market Estimates And Forecasts, 2021 - 2036 (USD Million)

Chapter 5. Medical AI Market: End Use Estimates & Trend Analysis

• 5.1. Medical AI Market: End Use Segment Dashboard
• 5.2. Medical AI Market: End Use Analysis, 2025 & 2036
• 5.3. Medical AI Market, By End Use, 2021 - 2036 (USD Billion)
• 5.4. By End Use
  • 5.4.1. Healthcare Providers
    • 5.4.1.1. Hospitals
      • 5.4.1.1.1. Hospitals Market Estimates And Forecasts, 2021 - 2036 (USD Million)
    • 5.4.1.2. Physician Groups/Clinics
      • 5.4.1.2.1. Physician Groups/Clinics Market Estimates And Forecasts, 2021 - 2036 (USD Million)
    • 5.4.1.3. Ambulatory / Specialty Care Centers
      • 5.4.1.3.1. Ambulatory / Specialty Care Centers Market Estimates And Forecasts, 2021 - 2036 (USD Million)
    • 5.4.1.4. Others
      • 5.4.1.4.1. Others Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 5.4.2. Life Sciences
    • 5.4.2.1. Pharmaceutical Companies
      • 5.4.2.1.1. Pharmaceutical Companies Market Estimates And Forecasts, 2021 - 2036 (USD Million)
    • 5.4.2.2. Biotechnology Companies
      • 5.4.2.2.1. Biotechnology Companies Market Estimates And Forecasts, 2021 - 2036 (USD Million)
    • 5.4.2.3. Cros / Clinical Research Organizations
      • 5.4.2.3.1. Cros / Clinical Research Organizations Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 5.4.3. Patient
    • 5.4.3.1. Patient Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 5.4.4. Payers
    • 5.4.4.1. Payers Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 5.4.5. Others
    • 5.4.5.1. Others Market Estimates And Forecasts, 2021 - 2036 (USD Million)

Chapter 6. Medical AI Market: Patient Journey Estimates & Trend Analysis

• 6.1. Medical AI Market: Patient Journey Segment Dashboard
• 6.2. Medical AI Market: Patient Journey Analysis, 2025 & 2036
• 6.3. Medical AI Market, By Patient Journey, 2021 - 2036 (USD Billion)
• 6.4. By Patient Journey
  • 6.4.1. Prevention/Wellness
    • 6.4.1.1. Prevention/Wellness Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 6.4.2. Diagnostics
    • 6.4.2.1. Diagnostics Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 6.4.3. Treatment / Intervention
    • 6.4.3.1. Treatment / Intervention Market Estimates And Forecasts, 2021 - 2036 (USD Million)
  • 6.4.4. Post-care / Management
    • 6.4.4.1. Post-care / Management Market Estimates And Forecasts, 2021 - 2036 (USD Million)

Chapter 7. Medical AI Market: Regional Analysis

• 7.1. Regional Outlook
• 7.2. North America
  • 7.2.1. North America Medical AI Market, 2021 - 2036 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Regulatory Framework
    • 7.2.2.3. Competitive Scenario
    • 7.2.2.4. U.S. Medical AI Market, 2021 - 2036 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Regulatory Framework
    • 7.2.3.3. Competitive Scenario
    • 7.2.3.4. Canada Medical AI Market, 2021 - 2036 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1. Key Country Dynamics
    • 7.2.4.2. Regulatory Framework
    • 7.2.4.3. Competitive Scenario
    • 7.2.4.4. Mexico Medical AI Market, 2021 - 2036 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Medical AI Market, 2021 - 2036 (USD Million)
  • 7.3.2. UK
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Regulatory Framework
    • 7.3.2.3. Competitive Scenario
    • 7.3.2.4. UK Medical AI Market, 2021 - 2036 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Regulatory Framework
    • 7.3.3.3. Competitive Scenario
    • 7.3.3.4. Germany Medical AI Market, 2021 - 2036 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Regulatory Framework
    • 7.3.4.3. Competitive Scenario
    • 7.3.4.4. France Medical AI Market, 2021 - 2036 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Regulatory Framework
    • 7.3.5.3. Competitive Scenario
    • 7.3.5.4. Italy Medical AI Market, 2021 - 2036 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Regulatory Framework
    • 7.3.6.3. Competitive Scenario
    • 7.3.6.4. Spain Medical AI Market, 2021 - 2036 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Regulatory Framework
    • 7.3.7.3. Competitive Scenario
    • 7.3.7.4. Denmark Medical AI Market, 2021 - 2036 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Regulatory Framework
    • 7.3.8.3. Competitive Scenario
    • 7.3.8.4. Sweden Medical AI Market, 2021 - 2036 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Regulatory Framework
    • 7.3.9.3. Competitive Scenario
    • 7.3.9.4. Norway Medical AI Market, 2021 - 2036 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Medical AI Market, 2021 - 2036 (USD Million)
  • 7.4.2. China
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. China Medical AI Market, 2021 - 2036 (USD Million)
  • 7.4.3. Japan
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Japan Medical AI Market, 2021 - 2036 (USD Million).
  • 7.4.4. South Korea
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Scenario
    • 7.4.4.4. South Korea Medical AI Market, 2021 - 2036 (USD Million)
  • 7.4.5. India
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Regulatory Framework
    • 7.4.5.3. Competitive Scenario
    • 7.4.5.4. India Medical AI Market, 2021 - 2036 (USD Million)
  • 7.4.6. Australia
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Regulatory Framework
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Australia Medical AI Market, 2021 - 2036 (USD Million)
  • 7.4.7. Thailand
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Regulatory Framework
    • 7.4.7.3. Competitive Scenario
    • 7.4.7.4. Thailand Medical AI Market, 2021 - 2036 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Medical AI Market, 2021 - 2036 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Brazil Medical AI Market, 2021 - 2036 (USD Million)
  • 7.5.3. Argentina
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Argentina Medical AI Market, 2021 - 2036 (USD Million)
• 7.6. Middle East & Africa
  • 7.6.1. Middle East & Africa Medical AI Market, 2021 - 2036 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. South Africa Medical AI Market, 2021 - 2036 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Saudi Arabia Medical AI Market, 2021 - 2036 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. UAE Medical AI Market, 2021 - 2036 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Kuwait Medical AI Market, 2021 - 2036 (USD Million)

Chapter 8. Medical AI Market: Competitive Landscape

• 8.1. Medical Imaging Diagnostics
  • 8.1.1. Participants' Overview
    • 8.1.1.1. Aidoc
    • 8.1.1.2. Lunit INC
    • 8.1.1.3. Behold.ai
    • 8.1.1.4. Digital Diagnostics INC.
    • 8.1.1.5. Tempus
    • 8.1.1.6. Viz.ai, INC.
    • 8.1.1.7. Us2.ai
    • 8.1.1.8. Rad AI
    • 8.1.1.9. Gleamer
    • 8.1.1.10. Enlitic
  • 8.1.2. Financial Performance
  • 8.1.3. Product Benchmarking
  • 8.1.4. Company/Competition Categorization
  • 8.1.5. Company Market Position Analysis, 2025
  • 8.1.6. Company Market Share Analysis By Medical Imaging Diagnostics, 2025 (%)
  • 8.1.7. Strategy Mapping
    • 8.1.7.1. New Product Launch
    • 8.1.7.2. Partnerships And Collaborations
    • 8.1.7.3. Regional Expansion
    • 8.1.7.4. Merger & Acquisition
    • 8.1.7.5. Others
• 8.2. Digital Pathology
  • 8.2.1. Participants' Overview
    • 8.2.1.1. Proscia INC.
    • 8.2.1.2. Aignostics, INC.
    • 8.2.1.3. Aiforia
    • 8.2.1.4. Dedalus S.p.a
    • 8.2.1.5. Gestalt
    • 8.2.1.6. Paige AI
    • 8.2.1.7. Path AI
    • 8.2.1.8. Ibex Medical Analytics
  • 8.2.2. Financial Performance
  • 8.2.3. Product Benchmarking
  • 8.2.4. Company/Competition Categorization
  • 8.2.5. Company Market Position Analysis, 2025
  • 8.2.6. Company Market Share Analysis By Digital Pathology, 2025 (%)
  • 8.2.7. Strategy Mapping
    • 8.2.7.1. New Product Launch
    • 8.2.7.2. Partnerships And Collaborations
    • 8.2.7.3. Regional Expansion
    • 8.2.7.4. Others
• 8.3. Genomic Diagnostics
  • 8.3.1. Participants' Overview
    • 8.3.1.1. Caris Life Sciences
    • 8.3.1.2. Tempus
    • 8.3.1.3. Sophia Genetics
    • 8.3.1.4. Genedx
    • 8.3.1.5. Fabric Genomics
    • 8.3.1.6. Genomenon
  • 8.3.2. Financial Performance
  • 8.3.3. Product Benchmarking
  • 8.3.4. Company/Competition Categorization
  • 8.3.5. Company Market Position Analysis, 2025
  • 8.3.6. Company Market Share Analysis By Genomic Diagnostics, 2025 (%)
  • 8.3.7. Strategy Mapping
    • 8.3.7.1. Product Launch
    • 8.3.7.2. Partnerships And Collaborations
    • 8.3.7.3. Product Expansion
    • 8.3.7.4. Merger & Acquisition
• 8.4. Bio-signal Diagnostics
  • 8.4.1. Participants' Overview
    • 8.4.1.1. Irhythm Technologies, INC.
    • 8.4.1.2. Beacon Biosignals
    • 8.4.1.3. Eko Health
    • 8.4.1.4. Anumana
    • 8.4.1.5. Cardiomatics
    • 8.4.1.6. Withings Health
    • 8.4.1.7. Medicalgorithmics.com
  • 8.4.2. Financial Performance
  • 8.4.3. Product Benchmarking
  • 8.4.4. Company/Competition Categorization
  • 8.4.5. Company Market Position Analysis, 2025
  • 8.4.6. Company Market Share Analysis By Bio-signal Diagnostics, 2025 (%)
  • 8.4.7. Strategy Mapping
    • 8.4.7.1. Product Launch
    • 8.4.7.2. Partnerships And Collaborations
    • 8.4.7.3. Merger & Acquisition
• 8.5. Multimodal Diagnostics
  • 8.5.1. Participants' Overview
    • 8.5.1.1. Tempus
    • 8.5.1.2. Viz.ai, INC.
    • 8.5.1.3. Aidoc
    • 8.5.1.4. Rapidai
    • 8.5.1.5. Annalise.ai
    • 8.5.1.6. Qure.ai
  • 8.5.2. Financial Performance
  • 8.5.3. Product Benchmarking
  • 8.5.4. Company/Competition Categorization
  • 8.5.5. Company Market Position Analysis, 2025
  • 8.5.6. Company Market Share Analysis By Multimodal Diagnostics, 2025 (%)
  • 8.5.7. Strategy Mapping
    • 8.5.7.1. Product Launch
    • 8.5.7.2. Partnerships And Collaborations
    • 8.5.7.3. Others
• 8.6. Clinical & Treatment Support
  • 8.6.1. Participants' Overview
    • 8.6.1.1. Openevidence
    • 8.6.1.2. Epic Systems Corporation
    • 8.6.1.3. Regard
    • 8.6.1.4. Ambience Healthcare
    • 8.6.1.5. Glass Health
    • 8.6.1.6. Wolters Kluwer
    • 8.6.1.7. Corti
    • 8.6.1.8. Nuance Communications
    • 8.6.1.9. Navina AI
  • 8.6.2. Financial Performance
  • 8.6.3. Product Benchmarking
  • 8.6.4. Company/Competition Categorization
  • 8.6.5. Company Market Position Analysis, 2025
  • 8.6.6. Company Market Share Analysis By Clinical & Treatment Support, 2025 (%)
  • 8.6.7. Strategy Mapping
    • 8.6.7.1. Product Launch
    • 8.6.7.2. Partnerships And Collaborations
    • 8.6.7.3. Others
• 8.7. Drug Discovery & Development
  • 8.7.1. Participants' Overview
    • 8.7.1.1. Bostongene Corporation
    • 8.7.1.2. Benevolentai
    • 8.7.1.3. Innophore
    • 8.7.1.4. Bioxcel Therapeutics INC.
    • 8.7.1.5. Owkin, INC
    • 8.7.1.6. Insilico Medicine
    • 8.7.1.7. Healx
    • 8.7.1.8. IBM
    • 8.7.1.9. Google (DeepMind)
    • 8.7.1.10. Biosymetrics, INC.
  • 8.7.2. Financial Performance
  • 8.7.3. Product Benchmarking
  • 8.7.4. Company/Competition Categorization
  • 8.7.5. Company Market Position Analysis, 2025
  • 8.7.6. Company Market Share Analysis By Drug Discovery & Development, 2025 (%)
  • 8.7.7. Strategy Mapping
    • 8.7.7.1. Product/Service Launch
    • 8.7.7.2. Partnerships And Collaborations
    • 8.7.7.3. Regional Expansion
    • 8.7.7.4. Merger & Acquisition
    • 8.7.7.5. Others
• 8.8. Robot-assisted Surgery
  • 8.8.1. Participants' Overview
    • 8.8.1.1. Intuitive Surgical
    • 8.8.1.2. Stryker
    • 8.8.1.3. Medtronic
    • 8.8.1.4. Johnson & Johnson Medtech
    • 8.8.1.5. Zimmer Biomet
    • 8.8.1.6. Activ Surgical
    • 8.8.1.7. Andromeda Surgical, INC.
    • 8.8.1.8. Algosurg
  • 8.8.2. Financial Performance
  • 8.8.3. Product Benchmarking
  • 8.8.4. Company/Competition Categorization
  • 8.8.5. Company Market Position Analysis, 2025
  • 8.8.6. Company Market Share Analysis By Robot-assisted Surgery, 2025 (%)
  • 8.8.7. Strategy Mapping
    • 8.8.7.1. New Product Launch
    • 8.8.7.2. Partnerships And Collaborations
    • 8.8.7.3. Regulatory Approval
    • 8.8.7.4. Regional Expansion
    • 8.8.7.5. Merger & Acquisition
    • 8.8.7.6. Others
• 8.9. Administrative Workflow Assistants
  • 8.9.1. Participants' Overview
    • 8.9.1.1. Waystar
    • 8.9.1.2. Abridge
    • 8.9.1.3. Notable Health
    • 8.9.1.4. Ambience Healthcare
    • 8.9.1.5. R1 Rcm
  • 8.9.2. Financial Performance
  • 8.9.3. Product Benchmarking
  • 8.9.4. Company/Competition Categorization
  • 8.9.5. Company Market Position Analysis, 2025
  • 8.9.6. Company Market Share Analysis By Administrative Workflow Assistants, 2025 (%)
  • 8.9.7. Strategy Mapping
    • 8.9.7.1. Product/Service Launch
    • 8.9.7.2. Partnerships And Collaborations
    • 8.9.7.3. Merger & Acquisition
• 8.10. Connected Medical Devices
  • 8.10.1. Participants' Overview
    • 8.10.1.1. Medtronic
    • 8.10.1.2. Abbott
    • 8.10.1.3. Dexcom
    • 8.10.1.4. Irhythm Technologies
    • 8.10.1.5. GE Healthcare
    • 8.10.1.6. Siemens Healthineers
    • 8.10.1.7. Koninklijke Philips N.v.
    • 8.10.1.8. Validic, INC.
    • 8.10.1.9. Biointellisense
    • 8.10.1.10. Healthsnap, INC.
    • 8.10.1.11. Roche
    • 8.10.1.12. Idoven
    • 8.10.1.13. Datos
  • 8.10.2. Financial Performance
  • 8.10.3. Product Benchmarking
  • 8.10.4. Company/Competition Categorization
  • 8.10.5. Company Market Position Analysis, 2025
  • 8.10.6. Strategy Mapping
    • 8.10.6.1. Product Launch
    • 8.10.6.2. Partnerships And Collaborations
    • 8.10.6.3. Product Expansion
• 8.11. Clinical Trials
  • 8.11.1. Participants' Overview
    • 8.11.1.1. Iqvia INC
    • 8.11.1.2. Dassault Systemes (Medidata)
    • 8.11.1.3. Insilico Medicine
    • 8.11.1.4. Tempus (Deep6.ai)
    • 8.11.1.5. NVIDIA Corporation
    • 8.11.1.6. Unlearn.ai, INC.
    • 8.11.1.7. Saama
    • 8.11.1.8. Antidote Technologies, INC.
    • 8.11.1.9. Phesi
  • 8.11.2. Financial Performance
  • 8.11.3. Product Benchmarking
  • 8.11.4. Company/Competition Categorization
  • 8.11.5. Company Market Position Analysis, 2025
  • 8.11.6. Company Market Share Analysis By Clinical Trials, 2025 (%)
  • 8.11.7. Strategy Mapping
    • 8.11.7.1. Product Launch
    • 8.11.7.2. Partnerships And Collaborations
    • 8.11.7.3. Merger & Acquisition
• 8.12. Fraud Detection
  • 8.12.1. Participants' Overview
    • 8.12.1.1. Codoxo
    • 8.12.1.2. Experian Information Solutions, INC.
    • 8.12.1.3. H2o.ai
    • 8.12.1.4. Optum, INC. (Unitedhealth Group)
    • 8.12.1.5. General Dynamics Information Technology, INC.
  • 8.12.2. Financial Performance
  • 8.12.3. Product Benchmarking
  • 8.12.4. Company/Competition Categorization
  • 8.12.5. Company Market Position Analysis, 2025
  • 8.12.6. Company Market Share Analysis By Fraud Detection, 2025 (%)
  • 8.12.7. Strategy Mapping
    • 8.12.7.1. Product Launch
    • 8.12.7.2. Partnerships And Collaborations
    • 8.12.7.3. Product Expansion
    • 8.12.7.4. Merger & Acquisition
• 8.13. Cybersecurity
  • 8.13.1 Participants' Overview
    • 8.13.1.1. CrowdStrike
    • 8.13.1.2. Palo Alto Networks
    • 8.13.1.3. Asimily
    • 8.13.1.4. Arctic Wolf
    • 8.13.1.5. Claroty
  • 8.13.2. Financial Performance
  • 8.13.3. Product Benchmarking
  • 8.13.4. Company/Competition Categorization
  • 8.13.5. Company Market Position Analysis, 2025
  • 8.13.6. Company Market Share Analysis By Cybersecurity, 2025 (%)
  • 8.13.7. Strategy Mapping
    • 8.13.7.1. Product Launch
    • 8.13.7.2. Merger & Acquisition
• 8.14. Dosage Error Reduction
  • 8.14.1. Participants' Overview
    • 8.14.1.1. Mvision AI INC.
    • 8.14.1.2. Dosemerx
    • 8.14.1.3. Merative
    • 8.14.1.4. Medaware
    • 8.14.1.5. Aicure
  • 8.14.2. Financial Performance
  • 8.14.3. Product Benchmarking
  • 8.14.4. Company/Competition Categorization
  • 8.14.5. Company Market Position Analysis, 2025
  • 8.14.6. Company Market Share Analysis By Dosage Error Reduction, 2025 (%)
  • 8.14.7. Strategy Mapping
    • 8.14.7.1. Regulatory Approval
    • 8.14.7.2. Partnerships And Collaborations
• 8.15. Precision Medicine
  • 8.15.1. Participants' Overview
    • 8.15.1.1. Bioxcel Therapeutics INC.
    • 8.15.1.2. Sanofi
    • 8.15.1.3. NVIDIA Corporation
    • 8.15.1.4. Alphabet INC. (Google)
    • 8.15.1.5. IBM
    • 8.15.1.6. Microsoft
  • 8.15.2. Financial Performance
  • 8.15.3. Product Benchmarking
  • 8.15.4. Company/Competition Categorization
  • 8.15.5. Company Market Position Analysis, 2025
  • 8.15.6. Company Market Share Analysis By Precision Medicine, 2025 (%)
  • 8.15.7. Strategy Mapping
    • 8.15.7.1. Partnerships And Collaborations
    • 8.15.7.2. Product Expansion
• 8.16. Wearables
  • 8.16.1. Participant's Overview
    • 8.16.1.1. Samsung Electronics Co., Ltd.
    • 8.16.1.2. Meta
    • 8.16.1.3. Fitbit, INC.
    • 8.16.1.4. Garmin LTD.
    • 8.16.1.5. Google, INC. (Alphabet)
    • 8.16.1.6. Huawei Technologies Co., Ltd.
    • 8.16.1.7. Xiaomi
    • 8.16.1.8. Apple, INC.
  • 8.16.2. Financial Performance
  • 8.16.3. Product Benchmarking
  • 8.16.4. Company/Competition Categorization
  • 8.16.5. Company Market Position Analysis, 2025
  • 8.16.6. Company Market Share Analysis By Wearables, 2025 (%)
  • 8.16.7. Strategy Mapping
    • 8.16.7.1. New Product Launch
    • 8.16.7.2. Mergers And Acquisitions
    • 8.16.7.3. Collaborations & Partnerships
    • 8.16.7.4. Regional Expansion
    • 8.16.7.5. Other Strategies
• 8.17. Patient Engagement
  • 8.17.1. Participants' Overview
    • 8.17.1.1. Medadvisor Solutions
    • 8.17.1.2. Innovaccer, INC.
    • 8.17.1.3. Enlivenhealth (A Subdivision Of Omnicell, INC.)
    • 8.17.1.4. Empirx Health, LLC.
    • 8.17.1.5. IBM
    • 8.17.1.6. Oracle
  • 8.17.2. Financial Performance
  • 8.17.3. Product Benchmarking
  • 8.17.4. Company/Competition Categorization
  • 8.17.5. Company Market Position Analysis, 2025
  • 8.17.6. Company Market Share Analysis By Patient Engagement, 2025 (%)
  • 8.17.7. Strategy Mapping
    • 8.17.7.1. Product Launch
    • 8.17.7.2. Partnerships And Collaborations
    • 8.17.7.3. Merger & Acquisition